Also in this playlist...
This transcript is automatically generated
And you reports that alzheimer's cases in the US will triple a by 2050 totally raising alarm about our ability to pay for these medical costs.
From this debilitating.
Disease which are projected to reach one point one trillion dollars.
With -- attention to this growing epidemic.
Fox News helped that come managing editor doctor Manny Alvarez joins us now it seems like you just hear more and more why well.
Because we're an aging population that's the whole key you know a lot of these chronic medical conditions whether you're talking about heart disease but especially.
Senile dementia parkinson's.
Is the consequences of an aging population people are living longer.
You know typically into their 70s80s.
And statistically as the population -- you gonna see this numbers increase.
Look my point fifty we gonna have a projection of about thirteen million Americans afflicted with.
So if you look at the clause which is about 200 billion dollars today is probably going to skyrocket to one trillion dollars.
That's the other aspect is for chronic medical conditions like say like diabetes or or -- or let's -- heart disease.
Out of pocket expenses for for a typical finally is about 2000 dollars.
And this out of pocket expense is not -- it's not reimbursable by the by the insurance company when you look at families with alzheimer's patient you're talking about 8000 dollars.
So a lot of expenses.
That's why -- got a little excited this morning when I read.
That the president is trying to.
And put it very big national project in sort of mapping out the human brain you know just like the genome project was a couple of hours ago.
Because I think that's very important -- -- -- -- there's no cure for this there's no cure we have the we have poor diagnosis and in in you know sort of that screening patients.
We don't know really what the risk factors are completely legal things like diabetes and then you know.
Chronic medical conditions like heart disease can put people at risk genetics are very important but we don't have good screening two tools.
And certainly we don't have very strong medications for treatment.
And they are indeed in you know in the medications that are are now in the bandwagon.
Are very expensive so when they do come out.
They're not gonna be a 100% efficacious and it's and the going to be.
Expenses you think it's odd thought that in this day -- age we have nothing to offer any -- patient.
-- known all but I I'd listen I think that mapping the human brain.
Which is the next frontier to me the next frontier is understanding the human brain.
From -- that neuro biology to that genetics.
To artificial intelligence which -- has implication.
Whole multi -- real plan in combination with the federal government and private industry.
Hopefully -- 23 years from now may break many of these things right now that -- we just don't know how to deal with so that I'm excited -- this is this is.
You know I'm you know I'm I'm not for a spending more dollars on the federal level but I think that mapping the human brain is the next frontier.
And I think something that needs to be done along those -- everybody knows somebody with alzheimer's and that's just the worst thing to watch right after many out RS thank thanks so much you -- about.
Filter by section